Pre-menstrual dysphoric disorder and pre-menstrual syndrome

  • Analysis of a menstrual distress questionnaire in pre-menstrual syndrome (PMS) using trial data
  • Consultation on a response to the FDA regarding the validation of a primary endpoint in pre-menstrual dysphoric disorder (PMDD)
  • Support of an endpoint dossier for regulatory submission in PMDD
  • Review and research of articles on PMDD criteria
  • Cross-validation of the Premenstrual Symptoms Screening Tool (PSST) and the Daily Record of Severity of Problems (DRSP) for use in patients with PMDD and PMS
  • Conference poster documenting the symptoms and impact of PMDD during the luteal phase and the appropriateness of the Daily Record of Severity of Symptoms Tool
  • Productivity assessment in PMDD